NanoPass Technologies and Micro2Nano (M2N) have agreed to collaborate on designing and manufacturing NanoPass's unique MEMS-based microneedles. The partnership aims to enhance the relationship between NanoPass and M2N and to lay the groundwork for the two firms' continuing growth, building on years of development and manufacturing collaboration.
Since 2007, M2N has been a vital and inseparable element of Nanopass's research and production operations, delivering high-quality foundry services, inventiveness, and rapid turnaround on development projects. The patented technological foundation of NanoPass is built on hollow, pyramid-shaped microneedles. It is manufactured utilizing MEMS technology using silicon crystals. The method may be utilized to administer a wide variety of injectable intradermals, including vaccinations and treatments, aesthetics, and cosmetics.
M2N has been developing and manufacturing MEMS-based microneedles with NanoPass for more than 14 years. It's an amazing thing considering the average lifespan of a company in recent years. During this long period of time, we have built a strong business relationship based on trust. We are excited to provide high-quality microneedles to NanoPass as a Prime Manufacturer and work with NanoPass as a Strategic R&D Partner to develop new business applications."
Kyuho Hwang, CEO of Micro2Nano
M2N has been a trusted partner for over a decade and has been assisting NanoPass regularly with both its development projects and ongoing commercial production." M2N provides ongoing, high-quality products with a quick response time and finds ingenious ways to solve complex problems. For us, trust is a crucial parameter for any partner, and M2N's organizational culture provides just the thing."
Yotam Levin, MD, CEO of NanoPass